Atossa Genetics Inc Stock Nasdaq
Equities
US04962H2094
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 192M 262M |
---|---|---|---|---|---|
Net income 2024 * | -35M -47.85M | Net income 2025 * | -41M -56.05M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.72
x | P/E ratio 2025 * |
-5.16
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.9% |
Latest transcript on Atossa Genetics Inc
Managers | Title | Age | Since |
---|---|---|---|
Shu-Chih Chen
FOU | Founder | 62 | 08-11-30 |
Steven Quay
CEO | Chief Executive Officer | 73 | 08-11-30 |
Heather Rees
DFI | Director of Finance/CFO | - | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Quay
CEO | Chief Executive Officer | 73 | 08-11-30 |
Director/Board Member | 66 | 14-02-28 | |
H. Remmel
BRD | Director/Board Member | 72 | 12-01-31 |
1st Jan change | Capi. | |
---|---|---|
+2.15% | 42.75B | |
+47.75% | 41.61B | |
+12.07% | 41.34B | |
-12.36% | 26.59B | |
+7.69% | 25.49B | |
-22.96% | 18.12B | |
+30.55% | 12.24B | |
-1.95% | 11.76B | |
+8.06% | 11B |